Mitra Biotech is a global leader in empowering oncology drug development. Our unique human ex vivo histoculture platform (CANscript™) characterizes human tumors that have been cultured in a fully recapitulated tumor microenvironment. The CANscript™ platform conserves tumor architecture and microenvironment and can be used to predict therapeutic response to a specific drug combination, as well as understand the mechanism of action of a given modality. Founded in 2010, Mitra Biotech is headquartered in the Boston area and maintains a significant research and laboratory presence in Bangalore, India.
Bio-Techne is a global life science company that is pioneering innovative solutions for cell and gene therapy manufacturing. Our expertise is in workflow reagents and instruments that facilitate the translation of scientific discoveries into preclinical and clinical studies. Our high-quality GMP portfolio, including the largest selection of cytokines for cell manufacturing, as well as our breadth of world-class immunoassays and antibodies makes us uniquely suited to support the development of macrophage-directed therapies.